The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Cancer statistics in China, 2015
Open accessAbstract
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid carcinomas are more prevalent among women.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [4]
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Self-citationGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Flagged first, then by citations
2 of the 85 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
- Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
- Chen Z, 2008, National Death Survey Report 2004–2005
- 2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
- Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131
Cited by
Sorted by citations
Items 701–800 of 1,032
Epidemiology of HPV Related Malignancies
Scott‐Wittenborn, N., & Fakhry, C. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.04.001 · Cited by 95
Ding, J., Sun, B., Song, P. K., Liu, S., Chen, H., Feng, M., & Guan, W. (2017) · Oncotarget · doi:10.18632/oncotarget.18581 · Cited by 94
Wang, Q., Zhao, J., Huo, X., Wu, L., Yang, L., Li, J., & Wang, J. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14515 · Cited by 94
Xue, X., Zhao, Y., Wang, X., Qin, L., & Hu, R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27165 · Cited by 95
Fan, R., Hu, P., Wang, Y., Lin, H.-Y., Su, K., Feng, X., Wei, L., & Yang, F. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.09.003 · Cited by 94
Effects of probiotics on chemotherapy in patients with lung cancer
Tian, Y., Li, M., Song, W., Jiang, R., & Li, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9906 · Cited by 95
Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer
Xue, J., Yu, X., Xue, L., Ge, X., Zhao, W., & Peng, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108921 · Cited by 96
Self-citationHuang, L., Wang, Y., Chen, J., Wang, Y., Zhao, Y., Wang, Y., Ma, Y., Chen, X., Liu, W., Li, Z., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1745-4 · Cited by 93
Aptamer-based electrochemical cytosensors for tumor cell detection in cancer diagnosis: A review
Sun, D., Lü, J., Zhang, L., & Chen, Z. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.07.054 · Cited by 94
Zhang, W., Wang, R., Ma, W., Wu, Y., Maskey, N., Guo, Y., Liu, J. T., Mao, S., Zhang, J., Yao, X., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.02 · Cited by 96
Cong, M., Feng, H., Ren, J., Xu, Q., Cong, L., Hou, Z.-Z., Wang, Y.-Y., & Shi, G. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.11.003 · Cited by 94
Luo, Q., Wu, X., Zhao, P., Nan, Y., Chang, W., Zhu, X., Su, D., & Liu, Z. (2021) · Advanced Science · doi:10.1002/advs.202002874 · Cited by 95
Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China
Liu, D., & Song, T. (2021) · BioScience Trends · doi:10.5582/bst.2021.01083 · Cited by 94
Chen, T., Liu, Y., Li, C., Xu, C., Ding, C., Chen, J., & Zhao, J. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100412 · Cited by 95
Yu, L., Liu, X., Wang, X., Yan, F., Wang, P., Jiang, Y., Du, J., & Yang, Z. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1942673 · Cited by 94
The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer
Sun, H., Wang, X., Wang, X., Xu, M., & Sheng, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05320-8 · Cited by 103
The landscape of cancer research and cancer care in China
Lu, Z., Chen, Y., Liu, D., Jiao, X., Liu, C. X., Wang, Y., Zhang, Z., Jia, K., Gong, J., Yang, Z., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02655-3 · Cited by 94
“Indus-trialization, urbanization and pollution have exacerbated the risk of cancer 8 .”
Metal peroxides for cancer treatment
He, J., Fu, L.-H., Qi, C., Lin, J., & Huang, P. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.026 · Cited by 93
Self-citationA miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance
Si, W., Shen, J., Du, C., Chen, D., Gu, X., Li, C., Yao, M., Pan, J., Cheng, J., Jiang, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.176 · Cited by 94
Human colorectal cancer progression correlates with LOX-induced ECM stiffening
Wei, B., Zhou, X., Liang, C., Zheng, X., Lei, P., Fang, J., Han, X., Wang, L., Qi, C., & Wei, H. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21230 · Cited by 93
Wu, J., Zhai, J., Li, C.-Y., Tan, A., Wei, P., Shen, L., & He, M. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0631-0 · Cited by 93
Small-Cell Lung Cancer Detection Using a Supervised Machine Learning Algorithm
Wu, Q., & Zhao, W. (2017) · International Symposium on Computer Science and Intelligent Control (ISCSIC) · doi:10.1109/iscsic.2017.22 · Cited by 93
Xu, W., He, L., Li, Y., Tan, Y. L., Zhang, F., & Xu, H. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1431518 · Cited by 93
Liu, Y., Lin, Z., Lin, Y., Chen, Y., Peng, X., He, F., Liu, S., Yan, S., Huang, L., Lu, W., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000754 · Cited by 93
Rui, X., Xu, Y., Jiang, X., Ye, W., Huang, Y., & Jiang, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1228-z · Cited by 93
Cui, Y., Xu, H., Liu, M., Xu, Y.-J., He, J., Zhou, Y., & Cang, S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i15.1890 · Cited by 93
Self-citationJiang, X., Li, J., Kan, Y., Yu, T., Chang, S., Sha, X., Zheng, H., Luo, Y., & Wang, S. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2963867 · Cited by 93
Xiao, J., Lin, L., Luo, D., Shi, L., Chen, W., Fan, H., Li, Z., Ma, X., Ni, P., Yang, L., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0215-2 · Cited by 95
Self-citationWang, Z., Wang, J., & He, J. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1198 · Cited by 93
Self-citationXian, J., Su, W., Liu, L., Rao, B., Lin, M., Feng, Y., Qiu, F., Chen, J., Zhou, Q., Zhao, Z., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.05.011 · Cited by 94
Development of a serum miRNA panel for detection of early stage non-small cell lung cancer
Ying, L., Du, L., Zou, R., Shi, L., Zhang, N., Jin, J., Xu, C., Zhang, F., Zhu, C. Y., Wu, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006212117 · Cited by 93
Zhou, Z., Liu, H., Yang, Y., Zhou, J., Zhao, L., Chen, H., Fei, Y., Zhang, W., Li, M., Zhao, Y., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12283 · Cited by 94
Polymeric micelle nanocarriers in cancer research
Shin, D. H., Tam, Y. T., & Kwon, G. S. (2016) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-016-1582-2 · Cited by 92
Zhong, J., Peng, N., You, X., Ma, L., Xiao, X., Wang, Y., Gong, W., Wu, F., Xiang, B., & Li, L.-Q. (2017) · Oncotarget · doi:10.18632/oncotarget.15433 · Cited by 92
Chinese health care system and clinical epidemiology
Sun, Y., Gregersen, H. N., & Yuan, W. (2017) · Clinical Epidemiology · doi:10.2147/clep.s106258 · Cited by 92
Yin, Y., Sui, C., Meng, F., Ma, P., & Jiang, Y. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0474-x · Cited by 92
Long noncoding RNA HAS2‐AS1 mediates hypoxia‐induced invasiveness of oral squamous cell carcinoma
Zhu, G., Wang, S., Chen, J., Wang, Z., Liang, X., Wang, X., Jiang, J., Lang, J., & Li, L. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22674 · Cited by 92
Cong, X. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-1538-9 · Cited by 92
Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
Yu, M., Guan, R., Hong, W., Zhou, Y., Lin, Y., Jin, H., Hou, B., & Jian, Z. (2019) · Cancer Management and Research · doi:10.2147/cmar.s196951 · Cited by 98
Huang, N., Guo, W., Ren, K., Li, W., Jiang, Y., Sun, J., Dai, W., & Zhao, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01103 · Cited by 92
Xiang, Y., Zhang, Q., Wei, S., Huang, C., Li, Z., & Gao, Y. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13204 · Cited by 94
Kong, F., Liu, X., Zhou, Y., Hou, X., He, J., Li, Q., Miao, X., & Yang, L. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105731 · Cited by 92
Self-citationYin, L., Lin, X., Li, N., Zhang, M., He, X., Liu, J., Kang, J., Chen, X., Wang, C., Wang, X., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1873 · Cited by 92
Qin, S., Li, Q., Xu, J., Liang, J., Cheng, Y., Fan, Y., Jiang, J., Ye, H., Tao, H., Li, L., et al. (2020) · Cancer Science · doi:10.1111/cas.14641 · Cited by 97
Progress of Breast Cancer basic research in China
Wang, X., Wang, C., Guan, J., Chen, B., Xu, L., & Chen, C. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60631 · Cited by 92
Yao, L., Chen, Z., Feng, Z., Diao, Y., Li, C., Sun, H.-Y., Zhong, J., Chen, T., Gu, W.-M., Zhou, Y.-H., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11454-y · Cited by 92
Ling, Y., Zhong, J., Weng, Z., Lin, G., Liu, C., Pan, C., Yang, H., Wei, X., Xie, X., Wei, X., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1074 · Cited by 92
Luo, D., Zhou, T., Tao, Y., Feng, Y., Shen, X., & Mei, S. (2016) · Scientific Reports · doi:10.1038/srep25768 · Cited by 100
Wu, Y., Wu, X., Wu, L., Wang, X., & Liu, Z. (2017) · Translational research · doi:10.1016/j.trsl.2017.08.004 · Cited by 92
Chen, W., Wang, J., Liu, S., Wang, S., Cheng, Y., Zhou, W., Duan, C., & Zhang, C. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0357-4 · Cited by 90
Self-citationWang, T., Ning, K., Lu, T., Sun, X., Jin, L., Qi, X., Jin, J., & Hua, D. (2016) · Cancer Science · doi:10.1111/cas.13150 · Cited by 92
Zeng, S., Xie, X., Xiao, Y., Tang, B., Hu, C.-J., Wang, S.-M., Wu, Y., Dong, H. F., Li, B., & Yang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.026 · Cited by 91
Sun, N., Zhang, G.-Z., & Liu, Y. (2018) · Gene · doi:10.1016/j.gene.2018.04.014 · Cited by 91
Antitumor effects of anlotinib in thyroid cancer
Ruan, X., Shi, X., Dong, Q., Yu, Y., Hou, X., Song, X., Wei, X., Chen, L., & Gao, M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0558 · Cited by 91
Chen, H., Sha, H., Zhang, L., Qian, H., Chen, F., Ding, N., Ji, L., Zhu, A., Xu, Q., Meng, F., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165109 · Cited by 91
Colonic Lysine Homocysteinylation Induced by High-Fat Diet Suppresses DNA Damage Repair
Wang, D., Zhao, R., Qu, Y., Mei, X., Zhang, X., Zhou, Q., Li, Y., Yang, S., Zuo, Z., Chen, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.022 · Cited by 91
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 93
Yu, L., Dong, L., Li, H. Z., Liu, Z., Luo, Z. Y., Duan, G., Dai, X., & Lin, Z. (2020) · Oncogene · doi:10.1038/s41388-020-1298-0 · Cited by 94
Zhang, X., Ruan, S., Xiao, W., Shao, J., Tian, W., Liu, W.-H., Zhang, Z., Wan, D.-L., Huang, J.-C., Huang, Q., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.111 · Cited by 80
Yoshino, T., Argilés, G., Oki, E., Martinelli, E., Taniguchi, H., Arnold, D., Mishima, S., Li, Y., Smruti, B. K., Ahn, J. B., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.08.1752 · Cited by 96
Meng, L., Zhang, Y., Wu, P., Li, D., Lu, Y., Shen, P., Yang, T., Shi, G., Chen, Q., Yuan, H., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01599-5 · Cited by 89
Han, X., Liu, Y., Gao, H., Ma, J., Mao, X., Wang, Y., & Ma, X. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.07.061 · Cited by 91
Zhang, H., Zhang, N., Liu, Y., Su, P., Liang, Y., Li, Y., Wang, X., Chen, T., Song, X., Sang, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1188 · Cited by 92
HOTTIP: a critical oncogenic long non-coding RNA in human cancers
Lian, Y., Cai, Z., Gong, H., Xue, S., Wu, D., & Wang, K. (2016) · Molecular BioSystems · doi:10.1039/c6mb00475j · Cited by 92
Zhu, G., Huang, Q., Huang, Y., Zheng, W., Jin, H., Yang, S., Zhuang, J., Wang, J., & Ye, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12449 · Cited by 91
Distinct prognostic values of S100 mRNA expression in breast cancer
Zhang, S., Wang, Z., Liu, W., Lei, R., Shan, J., Li, L., & Wang, X. (2017) · Scientific Reports · doi:10.1038/srep39786 · Cited by 90
Self-citationHsueh, C., Tao, L., Zhang, M., Cao, W., Gong, H., Zhou, J., & Zhou, L. F. (2017) · Oncotarget · doi:10.18632/oncotarget.16234 · Cited by 90
NEAT1/hsa‐mir‐98‐5p/MAPK6 axis is involved in non–small‐cell lung cancer development
Wu, F., Mo, Q., Wan, X., Dan, J., & Hu, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26442 · Cited by 90
A screening method for gastric cancer by oral microbiome detection
Sun, J., Li, X., Yin, J., Li, Y., Ben-xiang, H., & Zhang, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6286 · Cited by 93
Zeng, F., Chen, X., Cui, W., Wen, W., Lu, F., Sun, X., Ma, D., Yuan, Y., Li, Z., Hou, N., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3082 · Cited by 90
Chang, J., Zhong, R., Tian, J., Li, J., Zhai, K., Ke, J., Lou, J., Chen, W., Zhu, B., Shen, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0045-8 · Cited by 89
Self-citationJiang, J., Pi, J., Jin, H., & Cai, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27654 · Cited by 91
Wang, H., Du, P., Wu, M.-C., & Cong, W. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.09.05 · Cited by 90
Xiao, G., Yao, J., Kong, D.-P., Ye, C., Chen, R., Li, L., Zeng, T., Wang, L., Zhang, W., Shi, X., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.11.012 · Cited by 90
MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer
Wang, B., Qi, X., Liu, J., Zhou, R., Lin, C., Shangguan, J., Zhang, Z., Zhao, L., & Li, G. (2019) · Journal of Cancer · doi:10.7150/jca.27635 · Cited by 90
Deng, H., Shi, H., Chen, L., Zhou, Y., & Jiang, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0824-z · Cited by 90
Liao, H., Zhang, Z., Chen, J., Liao, M., Xu, L., Wu, Z., Yuan, K., Song, B., & Zeng, Y. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07815-9 · Cited by 90
Zhou, S., Liu, T., Zhou, J., Huang, Y., Guo, Y., Yu, J., Wang, Y., & Chang, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01591 · Cited by 90
Wang, F., Li, C., Li, S., Cui, L., Zhao, J., & Liao, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1133000 · Cited by 90
Yang, H., Li, Q., Chen, X., Weng, M., Huang, Y., Chen, Q., Liu, X., Huang, H., Feng, Y., Zhou, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48307-z · Cited by 91
“Gastric cancer (GC) ranks as the fi fth most frequent cancer and the fourth leading cause of cancer-relevant death around the world 1,2 .”
Gao, Y., Zhu, Y., Zhang, Z., Zhang, C., Huang, X., & Yuan, Z. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0340-0 · Cited by 89
Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer
Li, C., Li, Z., He, J., Fang, X.-Q., Zhu, S., & Xiong, M. (2016) · BMC Cancer · doi:10.1186/s12885-016-2719-x · Cited by 89
Self-citationLncRNA ANCR down-regulation promotes TGF-β-induced EMT and metastasis in breast cancer
Li, Z., Dong, M., Fan, D., Hou, P., Li, H., Liu, L., Lin, C., Liu, J., Su, L., Wu, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18622 · Cited by 91
Kou, L., Yao, Q., Sivaprakasam, S., Luo, Q., Sun, Y. H., Fu, Q., He, Z., Sun, J., & Ganapathy, V. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1377316 · Cited by 89
Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014
Li, X., Zheng, R., Li, X., Shan, H., Wu, Q., Wang, Y., & Chen, W. (2017) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2017.06.02 · Cited by 89
Self-citationMGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer
Wu, X., Luo, Q., Zhao, P., Chang, W., Wang, Y., Shu, T., Ding, F., Li, B., & Liu, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814742116 · Cited by 89
Li, N., Huang, H., Wu, D., Yang, Z., Wang, J., Wang, J., Wang, S., Fang, H., Yu, Y., Bai, Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30491-7 · Cited by 89
Self-citationZhang, F., Zhang, Y., Sun, Y., Ma, R., Thakur, K., Zhang, J., & Wei, Z. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07103 · Cited by 89
Cai, W., Dong, Z.-N., Fu, X.-T., Lin, L., Wang, L., Ye, G.-D., Luo, Q., & Chen, Y. (2020) · Theranostics · doi:10.7150/thno.47938 · Cited by 89
Mapping overdiagnosis of thyroid cancer in China
Li, M., Zheng, R., Maso, L. D., Zhang, S., Wei, W., & Vaccarella, S. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00083-8 · Cited by 89
Self-citationHong, J., Xu, X., Yang, J., Zheng, J., Dai, S.-M., Zhou, J., Zhang, Q., Ruan, Y., & Ling, C. (2021) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2021.10.004 · Cited by 86
Mo, S., Dai, W., Wang, H., Lan, X.-L., Ma, C., Su, Z., Xiang, W., Han, L., Luo, W., Zhang, L., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101717 · Cited by 95
Jiang, K., Yin, X., Zhang, Q., Yin, J., Tang, Q., Xu, M., Wu, L., Shen, Y., Zhou, Z., Yu, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102626 · Cited by 95
EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
Yi, X., Guo, J., Guo, J., Sun, S., Yang, P., Wang, J., Li, Y., Xie, L., Cai, J., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-03362-z · Cited by 90
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
Sheng, N., Li, Y., Wu, K., You, W., Gong, J., Hu, L., Tan, G., Chen, H., & Wang, Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0434-z · Cited by 90
Wang, C., Li, Z., Shao, F., Yang, X., Feng, X., Shi, S., Gao, Y., & He, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0555-8 · Cited by 89
Self-citationZhang, Z., Liu, Y., Liu, P., Yang, L., Jiang, X., Luo, D., & Yang, D. (2017) · Nanoscale · doi:10.1039/c7nr07337b · Cited by 88
Yu, C., Jiao, Y., Xue, J., Zhang, Q., Yang, H., Xing, L., Chen, G., Wu, J., Zhang, S., Zhu, W., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.18830 · Cited by 88
Self-citationCXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
Zhang, C., Li, Z., Xu, L., Che, X., Wen, T., Fan, Y., Li, C., Wang, S., Cheng, Y., Wang, X., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4384-8 · Cited by 88
Long non-coding RNAs in ovarian cancer
Zhan, L., Li, J., & Wei, B. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0793-4 · Cited by 89
Metadata
- Authors
- Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
- Affiliations
- Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Cancer Council Queensland (AU)
- Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Centre international de recherche sur le cancer (FR)
- American Cancer Society (US)
- The University of Sydney (AU)
- Director National Cancer Center Beijing China.
- Corresponding author
- Chen, Wanqing
- ORCID
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-01-25
- Volume
- 66
- Issue
- 2
- Pages
- 115-132
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2272984102
- Cited by
- 17,038
- References
- 85
- Citations by year
- 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
- FWCI
- 1269.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- CA A Cancer Journal for Clinicians (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, other-oa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- National Health and Family Planning Commission of China
- Ministry of Science and Technology (2014FY121100)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
- MeSH terms
- Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review